Bladder Cancer Advocacy Network (@bladdercancerus) 's Twitter Profile
Bladder Cancer Advocacy Network

@bladdercancerus

Elevating #BladderCancer awareness, advancing research, and providing educational and support services for the bladder cancer community.

ID: 240774855

linkhttp://www.BCAN.org calendar_today20-01-2011 18:25:02

10,10K Tweet

6,6K Takipçi

2,2K Takip Edilen

Armine Smith (@akfsurgeon) 's Twitter Profile Photo

"#bcantt24 Massive potential to improve urology practices! 🚭 Many patients are unaware that smoking cessation is crucial for bladder cancer prevention and treatment. Let's bridge the knowledge gap and make a difference! 💪 #BladderCancer #Urology #PublicHealth"

"#bcantt24 Massive potential to improve urology practices! 🚭 Many patients are unaware that smoking cessation is crucial for bladder cancer prevention and treatment. Let's bridge the knowledge gap and make a difference! 💪 #BladderCancer #Urology #PublicHealth"
Bladder Cancer Advocacy Network (@bladdercancerus) 's Twitter Profile Photo

In observance of the Labor Day holiday, BCAN's offices will be closed on Monday, September 2nd and we will reopen on September 3rd. Don't forget that we're always open at BCAN.org. Happy Labor Day, everyone!

In observance of the Labor Day holiday, BCAN's offices will be closed on Monday, September 2nd and we will reopen on September 3rd.  Don't forget that we're always open at BCAN.org.  Happy Labor Day, everyone!
Bladder Cancer Advocacy Network (@bladdercancerus) 's Twitter Profile Photo

According to this summary in @UroToday, the cost to treat bladder cancer in 2021 in the US was a staggering $6.5 billion. Click here to read more: urotoday.com/recent-abstrac…

Bladder Cancer Advocacy Network (@bladdercancerus) 's Twitter Profile Photo

Attention all junior investigators in #bladdercancer research! BCAN’s Career Development Award (CDA) is now open for submissions! Secure a 3-year, $250K grant to support your innovative research. Apply by October 11th, 2024. Learn more & retweet: bcan.org/bcan-research/…

Attention all junior investigators in #bladdercancer research! BCAN’s Career Development Award (CDA) is now open for submissions! Secure a 3-year, $250K grant to support your innovative research. Apply by October 11th, 2024. Learn more & retweet: bcan.org/bcan-research/…
Dra. María Natalia Gandur Quiroga (@nataliagandur) 's Twitter Profile Photo

🔝🔝🔝🎓Beautiful article, you must read it!! 💫🌟🔍 INDUCOMAIN Study: Evaluation of avelumab plus chemotherapy in cisplatin-ineligible metastatic urothelial carcinoma.🌟💫 Bego PValderrama Daniel Castellano Álvaro Pinto Javier Puente, Dr. E. Gonzalez-Billalabeitia, joaquim bellmunt. SOGUG

🔝🔝🔝🎓Beautiful article, you must read it!!
💫🌟🔍 INDUCOMAIN Study: Evaluation of avelumab plus chemotherapy in cisplatin-ineligible metastatic urothelial carcinoma.🌟💫
<a href="/begopval/">Bego PValderrama</a> <a href="/cdanicas/">Daniel Castellano</a> <a href="/dralvaropinto/">Álvaro Pinto</a> <a href="/docjavip/">Javier Puente</a>, Dr. E. Gonzalez-Billalabeitia,  <a href="/OncoBellmunt/">joaquim bellmunt</a>.
<a href="/sogug1/">SOGUG</a>
Bladder Cancer Advocacy Network (@bladdercancerus) 's Twitter Profile Photo

We've partnered with @cec_onc for a new #grandrounds activity on metastatic urothelial #carcinoma, hosted by Petros Grivas and Daniel Petrylak. Ready to elevate your community cancer care team? Book a live or virtual grand rounds today: ce.ceconcepts.com/BCAN-gr049058r…

Bladder Cancer Advocacy Network (@bladdercancerus) 's Twitter Profile Photo

In Urology Times: @laurabukavinamd on the need to integrate mental health support in GU cancer care. Click here to watch the video: urologytimes.com/view/laura-buk…

Tom Powles (@tompowles1) 's Twitter Profile Photo

Should Enfortumab Vedotin with Pembrolizumab be avoided due to baseline clinical conditions? Sometimes, but clinical judgement is more important than predefined criteria Andrea Apolo, M.D. Shilpa Gupta joaquim bellmunt Jonathan Rosenberg MD Michiel van der Heijden & Lisa Cordes gbr01.safelinks.protection.outlook.com/?url=https%3A%…

Should Enfortumab Vedotin with Pembrolizumab be avoided due to baseline clinical conditions? Sometimes, but clinical judgement is more important  than predefined  criteria <a href="/apolo_andrea/">Andrea Apolo, M.D.</a> <a href="/shilpaonc/">Shilpa Gupta</a> <a href="/OncoBellmunt/">joaquim bellmunt</a> <a href="/DrRosenbergMSK/">Jonathan Rosenberg MD</a> <a href="/MichvdHeijden/">Michiel van der Heijden</a> &amp; Lisa Cordes gbr01.safelinks.protection.outlook.com/?url=https%3A%…
Alan Tan (@alantanmd) 's Twitter Profile Photo

The Vanderbilt University Ingram Cancer Center Genitourinary team is expanding. We are seeking a GU medical oncology clinical investigator to join our innovative team. Please message me or Brian Rini, MD to inquire further. We will also be at #ESMO24

The Vanderbilt University Ingram Cancer Center Genitourinary team is expanding.  We are seeking a GU medical oncology clinical investigator to join our innovative team.  Please message me or <a href="/brian_rini/">Brian Rini, MD</a> to inquire further.  We will also be at #ESMO24
Bladder Cancer Advocacy Network (@bladdercancerus) 's Twitter Profile Photo

In @Urotoday: Artificial intelligence for predicting response to neoadjuvant chemotherapy for bladder cancer: A comprehensive systematic review and meta-analysis. Click to read the summary: urotoday.com/recent-abstrac…